Diaphoresis and pruritus with extended-release venlafaxine

Annals of Pharmacotherapy

Volumn 33, Issue 9, 1999, Pages 1009-

  Schwartz, Thomas L ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; PLACEBO; RISPERIDONE; SERTRALINE; VENLAFAXINE;

AGED; CASE REPORT; DELUSION; DEPRESSION; DIAPHORESIS; FEMALE; FOOD AND DRUG ADMINISTRATION; HUMAN; LETTER; PARKINSONISM; PRIORITY JOURNAL; PRURITUS; SIDE EFFECT; SUSTAINED RELEASE FORMULATION;

AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CYCLOHEXANOLS; DELAYED-ACTION PREPARATIONS; DEPRESSION; FEMALE; HUMANS; PRURITUS; SWEATING;

EID: 0032824371     PISSN: 10600280     EISSN: 15426270     Source Type: Journal    
DOI: 10.1345/aph.18398     Document Type: Letter

References (3)

1. Prescribing information. Effexor XR (extended-release venlafaxine). Philadelphia, PA: Wyeth-Ayerst Laboratories, October 1997.
2. Prescribing information. Effexor (venlafaxine). Philadelphia, PA: Wyeth-Ayerst Laboratories, April 1997.
3. Cunningham LA. Once-daily venlafaxine extended release and venlafaxine immediate release in outpatients with major depression. Ann Clin Psychiatry 1997;9:157–64.